Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA).
Kathrin ReetzRalf-Dieter HilgersSusanne IsfortMarc DohmenClaire DidszunKathrin FedosovJennifer KistermannCaterina MariottiAlexandra DurrSylvia BoeschThomas KlopstockFrancisco Javier Rodríguez de Rivera GarridoLudger SchölsThomas KlockgetherMassimo PandolfoRudolf KorinthenbergPhilip LavinGeert MolenberghsVincenzo LibriPaola GiuntiRichard FestensteinJörg B Schulznull nullPublished in: Neurological research and practice (2019)
EudraCT-No.: 2017-002163-17, ClinicalTrials.gov NCT03761511.